-
EP3297615
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3297615
| EP3297615 - METHODS AND PHARMACEUTICAL COMPOSITION FOR MODULATION POLARIZATION AND ACTIVATION OF MACROPHAGES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.06.2020 Database last updated on 07.06.2024 | |
| Former | Examination is in progress Status updated on 18.06.2019 | ||
| Former | Request for examination was made Status updated on 23.02.2018 | ||
| Former | The international publication has been made Status updated on 25.11.2016 | Most recent event Tooltip | 26.06.2020 | Application deemed to be withdrawn | published on 29.07.2020 [2020/31] | Applicant(s) | For all designated states INSERM - Institut National de la Santé et de la Recherche Médicale 101, rue de Tolbiac 75013 Paris / FR | For all designated states Universite Paris-Sud 15, rue Georges Clémenceau 91400 Orsay / FR | For all designated states Institut Gustave Roussy (IGR) 39, rue Camille Desmoulins 94800 Villejuif / FR | For all designated states Institut Pasteur 25-28, rue du Docteur Roux 75015 Paris / FR | For all designated states Assistance Publique - Hôpitaux de Paris 3 avenue Victoria 75004 Paris / FR | For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | For all designated states Université Paris Diderot (Paris 7) 5 Rue Thomas Mann 75013 Paris / FR | For all designated states Université Pierre et Marie Curie (Paris 6) 4, Place Jussieu 75005 Paris / FR | For all designated states Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" I.R.C.C.S Via Portuense 292 00149 Roma / IT | [N/P] |
| Former [2018/13] | For all designated states INSERM - Institut National de la Santé et de la Recherche Médicale 101, rue de Tolbiac 75013 Paris / FR | ||
| For all designated states Universite Paris-Sud 15, rue Georges Clémenceau 91400 Orsay / FR | |||
| For all designated states Institut Gustave Roussy (IGR) 39, rue Camille Desmoulins 94800 Villejuif / FR | |||
| For all designated states Institut Pasteur 25-28, rue du Docteur Roux 75015 Paris / FR | |||
| For all designated states Assistance Publique-Hôpitaux de Paris 3 avenue Victoria 75004 Paris / FR | |||
| For all designated states Université Paris Descartes 12, rue de l'Ecole de Médecine 75006 Paris / FR | |||
| For all designated states Université Paris Diderot (Paris 7) 5 Rue Thomas Mann 75013 Paris / FR | |||
| For all designated states Université Pierre et Marie Curie (Paris 6) 4, Place Jussieu 75005 Paris / FR | |||
| For all designated states Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" I.R.C.C.S Via Portuense 292 00149 Roma / IT | Inventor(s) | 01 /
PERFETTINI, Jean-Luc INSERM U1030 Gustave Roussy 114 rue Edouard Vaillant 94805 Villejuif / FR | 02 /
PAOLETTI, Audrey U1030 - Gustave Roussy Cancer Campus 114 rue Edouard Vaillant 94805 Villejuif / FR | 03 /
GOUGEON, Marie-Lise Unité Immunité Antivirale Biothérapies et Vaccins Institut Pasteur 25 rue du Dr Roux 75015 Paris / FR | 04 /
KROEMER, Guido. CENTRE BIOMEDICAL DES CORDELIERS 15 Rue de L`Ecole de Medecine Batiment B Paris 75006 / FR | 05 /
PIACENTINI, Mauro. Direttore Laboratorio di Biologia Cellulare Via Portuense 292 00149 Roma / IT | [2018/13] | Representative(s) | Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [N/P] |
| Former [2018/13] | Collin, Matthieu Inserm-Transfert Paris Biopark 7, rue Watt 75013 Paris / FR | Application number, filing date | 16725818.5 | 20.05.2016 | [2018/13] | WO2016EP61463 | Priority number, date | EP20150305759 | 20.05.2015 Original published format: EP 15305759 | [2018/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016185026 | Date: | 24.11.2016 | Language: | EN | [2016/47] | Type: | A1 Application with search report | No.: | EP3297615 | Date: | 28.03.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.11.2016 takes the place of the publication of the European patent application. | [2018/13] | Search report(s) | International search report - published on: | EP | 24.11.2016 | Classification | IPC: | A61K31/00, A61K38/00, A61K48/00, A61P35/00, A61P31/00, A61P37/00 | [2018/13] | CPC: |
A61K31/7072 (EP,US);
A61K31/7034 (EP,US);
A61K31/7076 (EP,US);
A61K31/7084 (US);
A61K38/177 (EP,US);
A61K48/00 (US);
A61P29/00 (EP,US);
A61P31/00 (EP,US);
A61P35/00 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/13] | Title | German: | VERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR MODULATIONSPOLARISIERUNG UND AKTIVIERUNG VON MAKROPHAGEN | [2018/13] | English: | METHODS AND PHARMACEUTICAL COMPOSITION FOR MODULATION POLARIZATION AND ACTIVATION OF MACROPHAGES | [2018/13] | French: | PROCÉDÉS ET COMPOSITION PHARMACEUTIQUE POUR LA MODULATION DE LA POLARISATION ET DE L'ACTIVATION DES MACROPHAGES | [2018/13] | Entry into regional phase | 14.11.2017 | National basic fee paid | 14.11.2017 | Designation fee(s) paid | 14.11.2017 | Examination fee paid | Examination procedure | 14.11.2017 | Amendment by applicant (claims and/or description) | 14.11.2017 | Examination requested [2018/13] | 14.11.2017 | Date on which the examining division has become responsible | 24.06.2019 | Despatch of a communication from the examining division (Time limit: M06) | 08.01.2020 | Application deemed to be withdrawn, date of legal effect [2020/31] | 24.01.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/31] | Divisional application(s) | EP19219435.5 / EP3685830 | Fees paid | Renewal fee | 25.05.2018 | Renewal fee patent year 03 | 10.05.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9834942 (INSPIRE PHARMACEUTICALS INC [US], et al) [X] 4-7 * page 14, line 15 - line 18 *; | [IY] - MICHAEL R. ELLIOTT ET AL, "Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance", NATURE, (20090910), vol. 461, no. 7261, doi:10.1038/nature08296, ISSN 0028-0836, pages 282 - 286, XP055091346 [I] 4-7 * page 284 - page 285 * [Y] 1-7 DOI: http://dx.doi.org/10.1038/nature08296 | [XI] - HOCHHAUSER EDITH ET AL, "P2Y2receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo", PURINERGIC SIGNALLING, SPRINGER VERLAG, DE, vol. 9, no. 4, doi:10.1007/S11302-013-9374-3, ISSN 1573-9538, (20130705), pages 633 - 642, (20130705), XP035311099 [X] 4,5 * figure 6 * * page 637, column l, paragraph 2 * * page 639, column l, paragraph 1 * [I] 2 DOI: http://dx.doi.org/10.1007/s11302-013-9374-3 | [Y] - RAFAEL FERNANDES ZANIN ET AL, "Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5'-Nucleotidase", PLOS ONE, (20120213), vol. 7, no. 2, doi:10.1371/journal.pone.0031205, page e31205, XP055216417 [Y] 1-7 * table 1 * * page 4, paragraph l - page 5, paragraph 1 * DOI: http://dx.doi.org/10.1371/journal.pone.0031205 | [Y] - BOURS M J L ET AL, "Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, vol. 112, no. 2, doi:10.1016/J.PHARMTHERA.2005.04.013, ISSN 0163-7258, (20061101), pages 358 - 404, (20061101), XP025038578 [Y] 1-7 * page 367, column r, paragraph 2 * * page 368, paragraph l - page 369 * DOI: http://dx.doi.org/10.1016/j.pharmthera.2005.04.013 | [Y] - JACOB FENILA ET AL, "Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses", PURINERGIC SIGNALLING, SPRINGER VERLAG, DE, vol. 9, no. 3, doi:10.1007/S11302-013-9357-4, ISSN 1573-9538, (20130213), pages 285 - 306, (20130213), XP035311090 [Y] 1-7 * page 289, column r, paragraph 2 * * figure 2; table 1 * DOI: http://dx.doi.org/10.1007/s11302-013-9357-4 | [XY] - BERGAMIN L S ET AL, "Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium", JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS INC, US, (20150501), vol. 116, no. 5, ISSN 0730-2312, pages 721 - 729, XP009186267 [X] 1-3 * page 721 - page 722, paragraph 1 * * page 724, column r, paragraph 1 * [Y] 1-7 DOI: http://dx.doi.org/10.1002/jcb.25018 | by applicant | US4816397 | US4946778 | US5225539 | US5789391 | US5837861 | WO9932619 | US5981732 | US6046321 | US6107091 | WO0136646 | WO0168836 | US6365354 | US6410323 | US2002082417 | US6506559 | US6566135 | US6566131 | US6573099 | WO2008060632 | - P. HILLMANN; G.-Y. KO; A. SPINRATH; A. RAULF; I. VON KÜGELGEN; S.C. WOLFF; R.A. NICHOLAS; E. KOSTENIS; H.-D. HOLTJE; C.E. MULLER, J. MED. CHEM., (2009), vol. 52, page 27620 | - SAUER R; EL-TAYEB A; KAULICH M; MULLER CE., "Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists", BIOORG MED CHEM., (20090530), vol. 17, no. 14, doi:doi:10.1016/j.bmc.2009.05.062, pages 5071 - 9, XP026302973 DOI: http://dx.doi.org/10.1016/j.bmc.2009.05.062 | - WEYLER S; BAQI Y; HILLMANN P; KAULICH M; HUNDER AM; MULLER IA; MULLER CE, "Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived Inhibitor of P2Y2 receptor activitys", BIOORG MED CHEM LETT., (20071030), vol. 18, no. 1, pages 223 - 7 | - FINLAY, B. B.; HANCOCK, R. E., "Can innate immunity be enhanced to treat microbial infections?", NATURE REVIEWS. MICROBIOLOGY, (2004), vol. 2, doi:doi:10.1038/nrmicro908, pages 497 - 504, XP009057908 DOI: http://dx.doi.org/10.1038/nrmicro908 | - MCMICHAEL, A. J.; KOFF, W. C., "Vaccines that stimulate T cell immunity to HIV-1: the next step", NATURE IMMUNOLOGY, (2014), vol. 15, pages 319 - 322 | - IWASAKI, A., "Innate immune recognition of HIV-1", IMMUNITY, (2012), vol. 37, pages 389 - 398 | - COX, A. L.; SILICIANO, R. F., "Making sense of HIV innate sensing", IMMUNITY, (2013), vol. 39, pages 998 - 1000 | - TOWERS, G. J.; NOURSADEGHI, M., "Interactions between HIV-1 and the cell-autonomous innate immune system", CELL HOST & MICROBE, (2014), vol. 16, doi:doi:10.1016/j.chom.2014.06.009, pages 10 - 18, XP028877419 DOI: http://dx.doi.org/10.1016/j.chom.2014.06.009 | - SILVIN, A.; MANEL, N., "Innate immune sensing of HIV infection", CURRENT OPINION IN IMMUNOLOGY, (2015), vol. 32C, pages 54 - 60 | - DOITSH, G. ET AL., "Cell death by pyroptosis drives CD4 T-cell depletion in HIVinfection", NATURE, (2014), vol. 505, pages 509 - 514 | - MONROE, K. M. ET AL., "IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV", SCIENCE, (2014), vol. 343, pages 428 - 432 | - DOITSH, G. ET AL., "Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue", CELL, (2010), vol. 143, doi:doi:10.1016/j.cell.2010.11.001, pages 789 - 801, XP028931200 DOI: http://dx.doi.org/10.1016/j.cell.2010.11.001 | - SEROR, C. ET AL., "Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.", THE JOURNAL OF EXPERIMENTAL MEDICINE, (2011), vol. 208, pages 1823 - 1834 | - SWARTZ, T. H.; ESPOSITO, A. M.; DURHAM, N. D.; HARTMANN, B. M.; CHEN, B. K., "P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection", JOURNAL OF VIROLOGY, (2014), vol. 88, pages 11504 - 11515 | - HAZLETON, J. E.; BERMAN, J. W.; EUGENIN, E. A., "Purinergic Receptors Are Required for HIV-1 Infection of Primary Human Macrophages", J IMMUNOL, (2012), vol. 188, doi:doi:10.4049/jimmunol.1102482, pages 4488 - 4495, XP055278464 DOI: http://dx.doi.org/10.4049/jimmunol.1102482 | - PAOLETTI, A. ET AL., "Multifaceted roles of purinergic receptors in viral infection", MICROBES AND INFECTION / INSTITUT PASTEUR, (2012), vol. 14, pages 1278 - 1283 | - "Mechanism of NLRP3 inflammasome activation", SUTTERWALA, F. S.; HAASKEN, S.; CASSEL, S. L., Annals of the New York Academy of Sciences, (2014), vol. 1319, pages 82 - 95 | - AGOSTINI, L. ET AL., "NALP3 forms an IL-lbeta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder", IMMUNITY, (2004), vol. 20, doi:doi:10.1016/S1074-7613(04)00046-9, pages 319 - 325, XP055015939 DOI: http://dx.doi.org/10.1016/S1074-7613(04)00046-9 | - HARI, A. ET AL., "Activation of NLRP3 inflammasome by crystalline structures via cell surface contact", SCIENTIFIC REPORTS, (2014), vol. 4, page 7281 | - ELLIOTT, M. R. ET AL., "Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance", NATURE, (2009), vol. 461, doi:doi:10.1038/nature08296, pages 282 - 286, XP055091346 DOI: http://dx.doi.org/10.1038/nature08296 | - KRONLAGE, M. ET AL., "Autocrine purinergic receptor signaling is essential for macrophage chemotaxis", SCIENCE SIGNALING, (2010), vol. 3, page RA55 | - MURRAY, P. J. ET AL., "Macrophage activation and polarization: nomenclature and experimental guidelines", IMMUNITY, (2014), vol. 41, pages 14 - 20 | - KRAUSGRUBER, T. ET AL., "IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses", NATURE IMMUNOLOGY, (2011), vol. 12, doi:doi:10.1038/ni.1990, pages 231 - 238, XP055025301 DOI: http://dx.doi.org/10.1038/ni.1990 | - BERGSBAKEN, T.; FINK, S. L.; COOKSON, B. T., "Pyroptosis: host cell death and inflammation", NATURE REVIEWS. MICROBIOLOGY, (2009), vol. 7, pages 99 - 109 | - DOSTERT, C. ET AL., "Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica", SCIENCE, (2008), vol. 320, pages 674 - 677 | - TSCHOPP, J.; SCHRODER, K., "NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?", NATURE REVIEWS. IMMUNOLOGY, (2010), vol. 10, pages 210 - 215 | - YOULE, R. J.; NARENDRA, D. P., "Mechanisms of mitophagy", NATURE REVIEWS. MOLECULAR CELL BIOLOGY, (2011), vol. 12, pages 9 - 14 | - ZHOU, R.; YAZDI, A. S.; MENU, P.; TSCHOPP, J., "A role for mitochondria in NLRP3 inflammasome activation", NATURE, (2011), vol. 469, pages 221 - 225 | - ALERS, S.; LOFFLER, A. S.; WESSELBORG, S.; STORK, B., "Role of AMPK-mTOR-Ulkl/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks", MOLECULAR AND CELLULAR BIOLOGY, (2012), vol. 32, doi:doi:10.1128/MCB.06159-11, pages 2 - 11, XP055265039 DOI: http://dx.doi.org/10.1128/MCB.06159-11 | - OKIGAKI, M. ET AL., "Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2003), vol. 100, pages 10740 - 10745 | - PY, B. F.; KIM, M. S.; VAKIFAHMETOGLU-NORBERG, H.; YUAN, J., "Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity", MOLECULAR CELL, (2013), vol. 49, pages 331 - 338 | - KANKKUNEN, P. ET AL., "Trichothecene mycotoxins activate NLRP3 inflammasome through a P2X7 receptor and Src tyrosine kinase dependent pathway.", HUMAN IMMUNOLOGY, (2014), vol. 75, pages 134 - 140 | - SANDILANDS, E. ET AL., "Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling", NATURE CELL BIOLOGY, (2012), vol. 14, pages 51 - 60 | - REISER, J. ET AL., "Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OFAMERICA, (1996), vol. 93, doi:doi:10.1073/pnas.93.26.15266, pages 15266 - 15271, XP000904382 DOI: http://dx.doi.org/10.1073/pnas.93.26.15266 | - HARRIS, R. S.; HULTQUIST, J. F.; EVANS, D. T., "The restriction factors of human immunodeficiency virus", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2012), vol. 287, pages 40875 - 40883 | - CASSOL, E.; CASSETTA, L.; ALFANO, M.; POLI, G., "Macrophage polarization and HIV-1 infection", JOURNAL OF LEUKOCYTE BIOLOGY, (2010), vol. 87, pages 599 - 608 | - VANDE WALLE, L. ET AL., "Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis", NATURE, (2014), vol. 512, pages 69 - 73 | - SHI, C. S. ET AL., "Activation of autophagy by inflammatory signals limits IL-lbeta production by targeting ubiquitinated inflammasomes for destruction", NATURE IMMUNOLOGY, (2012), vol. 13, pages 255 - 263 | - ALLOUCH, A. ET AL., "p21-mediated RNR2 repression restricts HIV- replication in macrophages by inhibiting dNTP biosynthesis pathway", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (2013), vol. 110, pages E3997 - 4006 | - HE, Y. ET AL., "3,4-methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2014), vol. 289, pages 1142 - 1150 | - SEYE, C. I.; YU, N.; GONZALEZ, F. A.; ERB, L.; WEISMAN, G. A., "The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule- expression through interaction with VEGF receptor-2 (KDR/Flk-1", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2004), vol. 279, pages 35679 - 35686 | - PERFETTINI, J. L. ET AL., "NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope", THE JOURNAL OF EXPERIMENTAL MEDICINE, (2004), vol. 199, doi:doi:10.1084/jem.20031216, pages 629 - 640, XP002289460 DOI: http://dx.doi.org/10.1084/jem.20031216 | - PERFETTINI, J. L. ET AL., "Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope", THE JOURNAL OF EXPERIMENTAL MEDICINE, (2005), vol. 201, pages 279 - 289 | - DELELIS, O. ET AL., "The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation", NUCLEIC ACIDS RESEARCH, (2009), vol. 37, pages 1193 - 1201 | - MELKI, M. T.; SAIDI, H.; DUFOUR, A.; OLIVO-MARIN, J. C.; GOUGEON, M. L., "Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.", PLOS PATHOGENS, (2010), vol. 6, page E1000862, XP002591180 | - HOMOLYA, L.; WATT, W. C.; LAZAROWSKI, E. R.; KOLLER, B. H.; BOUCHER, R. C., "Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1999), vol. 274, pages 26454 - 26460 | - JOHNSTON, L. K.; RIMS, C. R.; GILL, S. E.; MCGUIRE, J. K.; MANICONE, A. M., "Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, (2012), vol. 47, pages 417 - 426 | - DIOSZEGHY, V. ET AL., "Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression", JOURNAL OF VIROLOGY, (2006), vol. 80, pages 236 - 245 |